Braxia Scientific (TSE:BRAX) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Braxia Scientific Corp. has announced the successful election of its board of directors and the approval of a major asset sale at its recent Annual General and Special Meeting. The company, known for its innovative ketamine treatments for depression, is moving forward with the sale of its assets including the Canadian Rapid Treatment Center of Excellence. This move is part of Braxia’s proposed transaction aimed at enhancing its commitment to mental health treatments.
For further insights into TSE:BRAX stock, check out TipRanks’ Stock Analysis page.